ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
15.57
+0.39 (2.57%)
At close: Feb 27, 2026, 4:00 PM EST
15.28
-0.29 (-1.86%)
After-hours: Feb 27, 2026, 7:45 PM EST
ADMA Biologics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 510.17 | 426.45 | 258.22 | 154.08 | 80.94 | Upgrade
|
| Revenue Growth (YoY) | 19.63% | 65.16% | 67.58% | 90.36% | 91.72% | Upgrade
|
| Cost of Revenue | 217.41 | 206.9 | 169.27 | 118.82 | 79.77 | Upgrade
|
| Gross Profit | 292.77 | 219.55 | 88.94 | 35.27 | 1.17 | Upgrade
|
| Selling, General & Admin | 96.42 | 78.37 | 62.59 | 70.3 | 55.19 | Upgrade
|
| Research & Development | 4.76 | 1.81 | 3.3 | 3.61 | 2.85 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.14 | 0.39 | 0.72 | 0.72 | 0.72 | Upgrade
|
| Operating Expenses | 101.32 | 80.57 | 66.61 | 74.63 | 58.75 | Upgrade
|
| Operating Income | 191.44 | 138.98 | 22.33 | -39.37 | -57.57 | Upgrade
|
| Interest Expense | -7.11 | -13.93 | -25.03 | -19.28 | -13.06 | Upgrade
|
| Interest & Investment Income | 1.87 | 2.1 | 1.62 | 0.05 | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.21 | -0.19 | -0.29 | -0.64 | -0.25 | Upgrade
|
| EBT Excluding Unusual Items | 185.99 | 126.96 | -1.37 | -59.23 | -70.85 | Upgrade
|
| Other Unusual Items | -3.34 | -1.24 | -26.87 | -6.67 | -0.8 | Upgrade
|
| Pretax Income | 182.66 | 125.71 | -28.24 | -65.9 | -71.65 | Upgrade
|
| Income Tax Expense | 35.73 | -71.96 | - | - | - | Upgrade
|
| Net Income | 146.93 | 197.67 | -28.24 | -65.9 | -71.65 | Upgrade
|
| Net Income to Common | 146.93 | 197.67 | -28.24 | -65.9 | -71.65 | Upgrade
|
| Net Income Growth | -25.67% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 238 | 233 | 224 | 198 | 140 | Upgrade
|
| Shares Outstanding (Diluted) | 245 | 233 | 224 | 198 | 140 | Upgrade
|
| Shares Change (YoY) | 5.07% | 4.07% | 13.19% | 41.77% | 62.03% | Upgrade
|
| EPS (Basic) | 0.62 | 0.85 | -0.13 | -0.33 | -0.51 | Upgrade
|
| EPS (Diluted) | 0.60 | 0.81 | -0.13 | -0.33 | -0.51 | Upgrade
|
| EPS Growth | -25.93% | - | - | - | - | Upgrade
|
| Free Cash Flow | 27.82 | 110.45 | 4.03 | -73.42 | -125.88 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.47 | 0.02 | -0.37 | -0.90 | Upgrade
|
| Gross Margin | 57.38% | 51.48% | 34.45% | 22.89% | 1.45% | Upgrade
|
| Operating Margin | 37.52% | 32.59% | 8.65% | -25.55% | -71.13% | Upgrade
|
| Profit Margin | 28.80% | 46.35% | -10.94% | -42.77% | -88.52% | Upgrade
|
| Free Cash Flow Margin | 5.45% | 25.90% | 1.56% | -47.65% | -155.52% | Upgrade
|
| EBITDA | 199.54 | 147.03 | 30.66 | -32.25 | -52.08 | Upgrade
|
| EBITDA Margin | 39.11% | 34.48% | 11.88% | -20.93% | -64.34% | Upgrade
|
| D&A For EBITDA | 8.1 | 8.05 | 8.33 | 7.11 | 5.5 | Upgrade
|
| EBIT | 191.44 | 138.98 | 22.33 | -39.37 | -57.57 | Upgrade
|
| EBIT Margin | 37.52% | 32.59% | 8.65% | -25.55% | -71.13% | Upgrade
|
| Effective Tax Rate | 19.56% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.